Therapeutics

Bexarotene

Tools

Back to the Top

Overview

Name: Bexarotene
Synonyms: Targretin®
Therapy Type: Small Molecule
Target Type: Unknown
Condition(s): Mild Cognitive Impairment
U.S. FDA Status: Mild Cognitive Impairment (Phase 2)
Approved for: Cutaneous T-cell Lymphoma in US

Background

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

References

No Available References

Further Reading

No Available Further Reading